CARDIOTOXICITY ANTIPSYCHOTICS: MORPHO-ELECTROCARDIOGRAPHIC ASSOCIATIONS
https://doi.org/10.20996/1819-6446-2012-8-3-441-446
Abstract
Aim. To study the morphological and functional heart disorders in patients with different duration of antipsychotic treatment. Material and methods. Medical documents of 78 deceased schizophrenic patients treated with antipsychotic drugs were studied. The patients were split into 4 groups depending on duration of neuroleptic treatment: group 1 — <10 years, group 2 — 11-20 years; group 3 — 21-30 years, group 4 — >30 years. ECG-disorders and left ventricular morphometric data were analyzed. Сorrelation analysis of myocardium morphological changes and electrophysiological disorders was performed. Results. The dependence of morphometric myocardium changes on the treatment duration was found: increase in stromal-parenchymal ratio (from 9.9±4.1% to 80.0±10.1% in groups 1 and 4, respectively), in specific volume of atrophied cardiomyocytes (from 8.0±3.8% to 45.1±12.6% in groups 1 and 4, respectively), in specific volume of degenerative cardiomyocytes (from 5.2±3.1% to 35.2±12.1% in groups 1 and 4, respectively). Increased incidence of extrasystole detection (from 2.2% to 11.2% in groups 1 and 2, respectively), as well as left anterior fascicular block (from 1.1% to 25.9% in groups 1 and 2, respectively) and left ventricle hypertrophy (from 2.2% to 18.5% in groups 1 and 4, respectively) were found. A strong positive correlation (r=0.88–0.99) was revealed between antipsychotic treatment duration and ECG disorders, as well as between morphological myocardium state and ECG disorders. Conclusion. Awareness about the neuroleptic-depended ECG changes is necessary for early diagnosis, secondary prevention and correction of existing heart disorders due to cardiotoxic side effects of antipsychotic drugs.
About the Author
V. P. Volkov
Regional Clinical Psychiatric Hospital № 1 named after M. P . Litvinov
Russian Federation
Russian Federation
References
1. Volkov VP . Cardiotoxicity phenothiazine neuroleptics (review). Psikhiatriya i Psikhofarmakoterapiya 2010; 12(2): 41–5. Russian (Волков В.П. Кардиотоксичность фенотиазиновых нейролептиков (обзор литературы). Психиатрия и Психофармакотерапия 2010;12(2):41–5).
2. Drobizhev MYu. Cardiac problems of tolerability and safety of antipsychotic. Psikhiatriya i Psikhofarmakoterapiya 2004; 6(2): 13–7. Russian (Дробижев М.Ю. Кардиологические проблемы переносимости и безопасности нейролептика. Психиатрия и Психофармакотерапия 2004; 6(2): 13–7).
3. Limankina IN. Electrocardiographic phenomena in psychiatric practice. St. Petersburg: Inkart; 2009. Russian (Лиманкина И.Н. Электрокардиографические феномены в психиатрической практике. СПб.: Инкарт; 2009).
4. Buckley NA, Sanders P . Cardiovascular adverse effects of antipsychotic drugs. Drug Saf.
5. Coulter DM, Bate A, Meyboom RHB et al. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study. Br Med J 2001; 32:1207–9.
6. Volkov VP . Phenothiazine-induced dilatation cardiomyopathy: selected aspects of clinical course and morphology. Klin Med (Mosk) 2009;87(8):13–6. Russian (Волков В.П. Фенотиазиновая дилатационная кардиомиопатия: некоторые аспекты клиники и морфологии. Клиническая Медицина 2009;87(8):13–6).
7. Volkov VP . Peculiarities of ECG in patients with phenothiazine-induced cardiomyopathy. Klin Med (Mosk) 2011;89(4):27–30. Russian (Волков В.П. Особенности электрокардиограммы при фенотиазиновой кардиомиопатии. Клиническая медицина 2011;89(4):27–30).
8. Gurevich MA. Noncoronary myocardial diseases in the practice of cardiology. Spravochnik Poliklinicheskogo Vracha 2005;4(4): 30–35. Russian (Г уревич М.А. Некоронарогенные заболевания миокарда в практической кардиологии. Справочник Поликлинического Врача 2005;4(4): 30–35).
9. de Luna AB. Clinical Electrocardiography: A Textbook. 4th ed. Oxford, UK: Wiley-Blackwell; 2012
10. Orlov VN. Guidelines for electrocardiography . Moscow: Meditsinskoe Informatsionnoe Agentstvo; 1997. Russian (Орлов В.Н. Руководство по электрокардиографии. М.: МИА; 1997).
11. Shumakov VI, Khubutiya MSh, Il'inskiy IM. Dilated cardiomyopathy. T ver': Triada; 2003. Russian (Шумаков В.И, Хубутия М.Ш, Ильинский И.М. Дилатационная кардиомиопатия. Т верь: Триада; 2003).
12. Volkov VP . The role of neuroleptics fenotiazinovyh in the development of the syndrome of dilated cardiomyopathy. Verkhnevolzhskiy Meditsinskiy Zhurnal 2008;7(4):13–7. Russian (Волков ВП. К вопросу о роли фенотиазиновых нейролептиков в развитии синдрома дилатационной кардиомиопатии. Верхневолжский Медицинский Журнал 2008;7(4):13–7).
13. Volkov VP , Ryabova MN. Dilated cardiomyopathy as a complication of drug therapy. Verkhnevolzhskiy Meditsinskiy Zhurnal 2007;5(3–4):13–7. Russian (Волков В.П, Рябова М.Н. Дилатационная кардиомиопатия как осложнение лекарственной терапии. Верхневолжский медицинский журнал 2007;5(3–4):13–7).
14. Avtandilov GG. Medical morphometry. Moscow: Meditsina; 1990. Russian (Автандилов Г .Г . Медицинская морфометрия. М.: Медицина;1990).
15. Gutsol AA, Kondrat'ev BYu. Practical morphometry of organs and tissues. Tomsk: Tomskiy Universitet; 1988. Russian (Г уцол А.А, Кондратьев Б.Ю. Практическая морфометрия органов и тканей. Томск: Томский Университет; 1988).
16. Kazakov V .A., Gutor S.S., Sukhodolo I.V . et al. The correlation relationship of myocardial histomorphometric indices of various parts of the heart in health and chronic heart failure. Byulleten' Sibirskoy Meditsiny 2009; (3): 43-48. Russian (Казаков В.А., Г утор С.С., Суходоло И.В. и др. Корреляционные взаимосвязи гистоморфометрических показателей миокарда различных отделов сердца в норме и при хронической сердечной недостаточности. Бюллетень Сибирской Медицины 2009; (3): 43-48).
17. Sepetliev DA. Statistical methods in scientific and medical research. Moscow: Meditsina; 1968. Russian (Сепетлиев Д.А. Статистические методы в научных медицинских исследованиях. М.: Медицина; 1968).
18. Nepomnyashchikh LM. Morphogenesis of the most important pathological processes in the heart. Novosibirsk: Nauka; 1991. Russian (Непомнящих ЛМ. Морфогенез важнейших общепатологических процессов в сердце. Новосибирск: Наука; 1991).
19. Prokop'eva SN, Movchan LA, Iskhakova GG, Rozentsveyg AK. Features of electrocardiographic diagnosis in patients of older age groups. Prakticheskaya Meditsina 2008; 28: 21—29. Russian (Прокопьева С.Н, Мовчан Л.А, Исхакова Г .Г , Розенцвейг А.К. Особенности электрокардиографической диагностики у лиц старших возрастных групп. Практическая Медицина 2008; 28: 21–29).
20. Jones J, Sroduiski ZM, Romisher S. The aging electrocardiogram. Am J Emerg Med 1990: 8(3): 240–51.
21. Khane RS, Surdi AD, Bhatkar RS. Changes in ECG pattern with advancing age. J Bas Clin Physiol Pharmacol 2011; 22(4):97–101.
22. De Bacquer D, De Backer G, Kornitzer M. Prevalence of ECG findings in large population based samples of men and women. Heart 2000;84:625–33.
23. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram: prevalence, incidence, and mortality in the Framingham study. Ann Intern Med 1969; 71: 89–105.
24. Klyushin DA, Petunin YuI. Evidence-based medicine. Application of statistical methods. Moscow: Dialektika; 2008. Russian (Клюшин Д.А, Петунин Ю.И. Доказательная медицина. Применение статистических методов. М.: Диалектика; 2008).
Review
For citations:
Volkov V.P. CARDIOTOXICITY ANTIPSYCHOTICS: MORPHO-ELECTROCARDIOGRAPHIC ASSOCIATIONS. Rational Pharmacotherapy in Cardiology. 2012;8(3):441-446. (In Russ.) https://doi.org/10.20996/1819-6446-2012-8-3-441-446
Views:
1086
Email this article 